ADAR1 Capital Management »

Nuvei Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Nuvei Corporation (NVEI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Nuvei Corporation

Tip: Access up to 7 years of quarterly data

All positions including Nuvei Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvei Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $158k 5.0k 31.62

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Nuvei Corporation

TIG Advisors
Vanguard Group
Omni Event Management
Pentwater Capital Management
Glazer Capital
Man Group
PSquared Asset Management
Qube Research & Technologies
Jpmorgan Chase & Co
Vivaldi Asset Management
Goldman Sachs Group
Highland Capital Management Fund Advisors
Bank of America Corporation
Alpine Associates Management
Polar Securities

View all funds holding Nuvei Corporation